Dolby Laboratories (DLB) Stock Price

Currency:

Dolby Laboratories Price

🇺🇸NYSE·CLOSED

63.86USD

Market closed

Today +/-

-0.10 USD

Today %

-0.16 %

Dolby Laboratories (DLB) — ISIN US25659T1079. The Dolby Laboratories stock price was 63.86 USD in 2026. Revenue was 1.43 B USD. Earnings were 420.08 M USD. P/E ratio was 14.82. Dolby Laboratories operates in the Information technology sector.

Dolby Laboratories stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Dolby Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Dolby Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Dolby Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Dolby Laboratories Stock Price History

Date	Dolby Laboratories Price
3/11/2026	63.86 USD
3/10/2026	63.96 USD
3/9/2026	65.25 USD
3/6/2026	64.95 USD
3/5/2026	65.48 USD
2/26/2026	65.45 USD
2/25/2026	64.29 USD
2/24/2026	64.01 USD
2/23/2026	63.78 USD
2/20/2026	64.05 USD
2/19/2026	64.26 USD
2/18/2026	64.73 USD
2/17/2026	63.89 USD
2/13/2026	66.48 USD
2/12/2026	66.58 USD
2/11/2026	69.20 USD
2/10/2026	68.28 USD

API Docs Get API Key

Dolby Laboratories Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

Dolby Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 12, 2026, 2:02 AM

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

DOCUMENTS

2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e	2027e	2028e
0.11	0.12	0.16	0.22	0.29	0.33	0.39	0.48	0.64	0.72	0.92	0.96	0.93	0.91	0.96	0.97	1.03	1.08	1.05	1.24	1.16	1.28	1.25	1.3	1.27	1.35	1.43	1.49	1.57
–	11.71	29.84	34.78	33.18	13.49	19.21	23.27	32.78	12.34	28.23	4.23	-2.91	-2.57	5.61	1.04	5.67	5.37	-2.41	17.74	-6.45	10.34	-2.19	3.67	-2.00	5.97	6.15	3.91	5.58
58.56	59.68	64.60	65.90	68.17	75.30	80.56	84.44	89.38	90.96	85.68	88.35	90.14	89.44	92.71	90.21	89.37	88.98	87.95	87.03	87.42	89.85	88.75	88.30	89.00	88.14	83.03	79.91	75.68
0.07	0.07	0.1	0.14	0.2	0.25	0.32	0.41	0.57	0.65	0.79	0.85	0.84	0.81	0.89	0.88	0.92	0.96	0.93	1.08	1.02	1.15	1.11	1.15	1.13	1.19	1.19	1.19	1.19
3	5	0	31	39	52	89	142	199	243	283	309	264	189	206	181	185	206	41	255	231	310	184	200	261	255	420	447	490
–	66.67	–	–	25.81	33.33	71.15	59.55	40.14	22.11	16.46	9.19	-14.56	-28.41	8.99	-12.14	2.21	11.35	-80.10	521.95	-9.41	34.20	-40.65	8.70	30.50	-2.30	64.71	6.43	9.62
-	-	-	-	-	-	-	-	-	-	-	-	4.00	-	0.10	0.42	0.50	0.58	0.67	0.79	0.88	0.91	1.02	1.11	1.23	1.35	0.36	2.09	2.32
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	320.00	19.05	16.00	15.52	17.91	11.39	3.41	12.09	8.82	10.81	9.76	-73.33	480.56	11.00
85	85	85	86.1	92.8	104.2	111.7	113.6	114.8	115.4	115.4	112.6	107.5	102.8	103.6	103.9	102.4	103.3	107	104.6	102.9	104.6	102	97.7	97.33	97.48	97.48	97.48	97.48
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Dolby Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Dolby Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Dolby Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Dolby Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Dolby Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (B USD)

RECEIVABLES (M USD)

OTHER RECEIVABLES (M USD)OTHER REC. (M USD)

INVENTORIES (M USD)

OTHER CURRENT ASSETS (M USD)OTHER CURRENT LIAB. (M USD)

CURRENT ASSETS (B USD)

TANGIBLE ASSETS (M USD)

LONG-TERM INVESTMENTS (M USD)LONG-T. INVEST. (M USD)

LONG-TERM RECEIVABLES (M USD)LONG-T. REC. (M USD)

INTANGIBLE ASSETS (M USD)INTANGIBLE ASSETS (M USD)

GOODWILL (M USD)

OTHER NON-CURRENT ASSETS (M USD)OTHER NON-CURRENT ASSETS (M USD)

NON-CURRENT ASSETS (B USD)

TOTAL ASSETS (B USD)

LIABILITIES

COMMON STOCK (k USD)

ADDITIONAL PAID-IN CAPITAL (M USD)

RETAINED EARNINGS (B USD)

OTHER EQUITY (M USD)OTHER EQUITY (M USD)

UNREALIZED GAINS/LOSSES (M USD)UNREAL. GAINS/LOSSES (M USD)

EQUITY (B USD)

LIABILITIES (M USD)

PROVISIONS (M USD)

OTHER SHORT-TERM LIABILITIES (M USD)OTHER SHORT-TERM LIAB. (M USD)

SHORT-TERM DEBTS (M USD)SHORT-TERM DEBTS (M USD)

SHORT-TERM PORTION OF LONG-TERM DEBTS (M USD)LONG-TERM DEBT PORTION (M USD)

SHORT-TERM RECEIVABLES (M USD)SHORT-TERM REC. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIAB. (M USD)

DEFERRED TAXES (M USD)

OTHER LIABILITIES (M USD)OTHER LIAB. (M USD)

LONG-TERM LIABILITIES (M USD)LONG-T. LIABILITIES (M USD)

DEBT (M USD)

TOTAL CAPITAL (B USD)

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025

0.06	0.08	0.37	0.49	0.6	0.51	0.74	0.85	0.94	0.8	0.59	0.8	0.67	0.64	0.87	1.1	0.92	1.12	1.26	0.81	0.88	0.48	0.7
14.1	20.2	25.2	23.6	28.2	27.7	23	54.3	61.8	43.5	97.5	86.2	101.6	75.7	73.8	332.1	384.8	341.7	414.9	419.7	444.4	512.94	511.9
1.7	4.2	8	1.3	0	0	4.5	3.5	7.8	5.7	7.9	4	10.8	1.3	2.4	2.4	0.7	0	0	0	0	0	0
4.2	7.2	11.7	11.1	14.9	18.1	13	28.3	26.2	16.7	10.1	8.5	13.9	16.4	25.1	26.2	32.3	25.6	11	23.5	35.6	33.73	30.42
23.6	34.4	36.8	50.9	90.7	131.6	124.9	126.2	120	109.1	108.5	107.4	24.2	28.6	35.4	39.6	47.3	61.1	70.4	58.4	123.3	165.7	143.34
0.11	0.14	0.45	0.57	0.73	0.69	0.9	1.06	1.16	0.97	0.82	1.01	0.82	0.76	1.01	1.5	1.38	1.55	1.76	1.31	1.49	1.19	1.39
65.7	72.3	76.5	77	85.6	87.9	92.2	94.1	117.1	254.7	242.9	289.8	403.1	443.7	485.3	514.2	537.4	618.5	601.5	560	521.8	518.16	503.81
3.8	0.2	0	32.9	73.2	181	205.9	190.8	272.8	361.6	306.3	296.3	321	393.9	314.4	187.8	179.6	52.1	62.8	102.5	97.8	89.27	80.21
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
5.6	6.8	17.2	15	35.4	83.1	82	67	51.6	56.5	41.3	63.7	127.5	215.3	189.6	184	180.9	152.4	122.9	112.3	167.4	434.51	397.06
8.7	22	23.9	23.2	39.4	250.4	261.1	264.6	263.3	281.4	279.7	277.6	307.7	309.6	311.1	328	334.8	336.9	340.7	365.1	408.4	533.21	529.9
13.3	15.7	14.6	18.6	24.8	42	39.2	34.8	21.1	36.3	49.1	50.8	152.7	187.9	221.7	154.8	207.5	210.1	217.3	238.7	296.5	340.37	328.53
0.1	0.12	0.13	0.17	0.26	0.64	0.68	0.65	0.73	0.99	0.92	0.98	1.31	1.55	1.52	1.37	1.44	1.37	1.35	1.38	1.49	1.92	1.84
0.2	0.26	0.59	0.74	0.99	1.34	1.58	1.71	1.88	1.96	1.74	1.98	2.13	2.31	2.53	2.87	2.82	2.92	3.11	2.69	2.98	3.11	3.23

100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100	94	94
7	48.7	308.4	323.4	375.8	434.9	479	329.9	210.7	0	18.8	46.4	17.6	42	61.3	66.1	0	0	0	0	0	0	0
0.09	0.13	0.18	0.27	0.41	0.61	0.85	1.14	1.45	1.71	1.45	1.66	1.8	1.94	2.08	2.31	2.33	2.44	2.61	2.3	2.39	2.5	2.63
1.5	-30.6	-24.7	3.8	11.5	4.7	9.5	6.2	6.8	9.6	7.6	2.5	-11.5	-10.9	-7.4	-12.9	-22.8	-11.4	-10.3	-45.7	-34.1	-19.1	-12.52
0	0	0	0	0	0	0	1.6	0.7	1.1	0.2	0.5	0	0.7	-0.4	-2.9	2.2	0.8	0.2	-6	-2.9	-0.08	0
0.09	0.14	0.46	0.59	0.8	1.05	1.34	1.47	1.66	1.72	1.48	1.71	1.81	1.97	2.14	2.36	2.31	2.43	2.6	2.25	2.36	2.48	2.62
9.6	6.5	6.5	4.6	9.3	10.1	12.9	3.6	10.9	14.8	10.7	15.9	20.7	17.5	14.4	21.9	15.2	12.6	17.8	14.2	20.9	17.38	17.84
33.8	50.3	58.6	74.8	84	106.5	72	98.9	74.5	80.6	97.7	114.9	128.8	134.6	157.9	174.1	209.2	175.4	205.3	180.4	214.5	203.3	213.33
7	6.4	6.3	12.1	48.4	82.4	70	63.3	74	61.4	64.4	58.5	60.1	61	73.5	89.2	82.4	79.1	92.7	83	186.8	197.16	206.63
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.1	1.3	1.3	1.4	1.6	1.6	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
51.5	64.5	72.7	92.9	143.3	200.6	156.5	165.8	159.4	156.8	172.8	189.3	209.6	213.1	245.8	285.2	306.8	267.1	315.8	277.6	422.2	417.84	437.79
14.5	13.6	12.1	10.9	9.7	7.8	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	16.8	13.6	11.5	0.7	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0
26.9	23.3	22	21.3	19.4	39.6	42.2	39.8	39	58	65.1	63	107.6	118.3	143.9	209.7	201.9	211.8	185.7	161	185.4	205.2	158.02
41.4	36.9	34.1	32.2	29.1	64.2	61.6	51.3	39.7	60.7	65.1	63	107.6	118.3	143.9	209.7	201.9	211.8	185.7	161	185.4	205.2	158.02
92.9	101.4	106.8	125.1	172.4	264.8	218.1	217.1	199.1	217.5	237.9	252.3	317.2	331.4	389.7	494.9	508.7	478.9	501.5	438.6	607.6	623.04	595.81
0.19	0.24	0.57	0.72	0.97	1.31	1.56	1.69	1.86	1.94	1.72	1.96	2.12	2.3	2.53	2.86	2.82	2.91	3.1	2.68	2.96	3.1	3.22

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of Dolby Laboratories at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives Dolby Laboratories financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means Dolby Laboratories is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether Dolby Laboratories is strengthening or weakening its financial position.

NET INCOME (M USD)

DEPRECIATION AND AMORTIZATION M USDDEPRECIATION (M USD)

DEFERRED TAXES (M USD)

CHANGES IN WORKING CAPITAL (M USD)CHANGES IN WORKING CAPITAL (M USD)

NON-CASH ITEM (M USD)

PAID INTEREST (M USD)

PAID TAXES (M USD)

Net Cash Flow from Operating Activities (M USD)NET CASH FLOW FROM OPERATING ACTIVITIES (M USD)

CAPITAL EXPENDITURES (M USD)

CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M USD)

INTEREST INCOME AND EXPENSES (M USD)

NET DEBT CHANGE (M USD)NET DEBT CHANGE (M USD)

Net change in equity (M USD)NET CHANGE IN EQUITY (M USD)

CASH FLOW FROM FINANCING ACTIVITIES (M USD)CASH FLOW FROM FINANCING ACTIVITIES (M USD)

OTHER ITEMS OF FINANCING CASH FLOWS (M USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M USD)

TOTAL DIVIDENDS PAID (M USD)

NET CHANGE IN CASH FLOW (M USD)

FREE CASH FLOW (M USD)

SHARE-BASED COMPENSATION (M USD)

2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
0	31	39	52	89	142	201	244	282	310	265	190	208	183	186	207	42	255	231	317	183	201	264	256
7	7	8	11	12	14	24	28	34	44	43	53	53	69	85	84	81	85	90	95	88	82	75	87
-13	-3	-10	0	-18	-33	-21	5	-16	6	1	-19	-6	-14	-22	-35	61	-40	-5	-37	-29	-18	-21	4
7	3	1	-1	44	43	59	-8	2	-10	15	-20	30	18	37	49	83	-94	-81	-24	-56	-42	-106	-17
21	0	6	18	23	15	23	25	51	96	111	137	141	119	140	137	154	198	194	195	246	261	235	268
1	2	2	2	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
11	18	40	36	51	75	102	113	141	122	98	77	72	51	55	56	60	59	52	70	40	61	63	73
22	39	46	80	132	163	264	273	327	403	389	276	361	309	360	377	352	327	343	447	318	367	327	472
-3	-6	-12	-26	-8	-15	-13	-23	-38	-47	-167	-30	-116	-195	-221	-104	-85	-113	-69	-54	-59	-30	-30	-41
-5	-14	-30	-31	-163	-192	-271	-236	-44	-236	-194	175	-204	-203	-282	-158	78	-56	134	-44	-295	54	-286	-10
-1	-7	-18	-4	-155	-177	-257	-212	-6	-189	-27	205	-88	-8	-60	-53	163	57	203	9	-236	84	-256	31
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-3	-1	-1	-1	-1	-1	-1	-1	-7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	1	246	7	10	14	17	-201	-169	-254	-75	-36	-94	-43	-47	-66	-306	-114	-156	-509	-132	-158	-118
-3	-1	0	244	20	30	34	21	-184	-162	-254	-488	-40	-138	-92	-106	-133	-385	-207	-252	-610	-236	-287	-247
0	0	0	0	13	21	21	5	24	6	0	-4	-4	-3	0	-2	-1	-1	-5	-7	-1	0	-15	-1
0	0	0	0	0	0	0	0	0	0	0	-408	0	-41	-48	-57	-66	-77	-88	-89	-100	-103	-114	-126
14	24	16	293	-8	4	26	56	94	5	-58	-38	114	-36	-15	114	290	-119	274	153	-604	189	-240	215
19	32.8	34.4	53.9	124.5	147.2	250.9	249.6	289	356.3	222.1	245.7	244.8	114.4	138.3	272.9	266.8	214.2	274.8	393.3	259.1	336.8	297.25	430.26
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

API Docs Get API Key

Dolby Laboratories Stock Quarterly Figures

REVENUE (M USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (M USD)

NET INCOME (M USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (M)

2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2e	2026 Q3e	2026 Q4e	2027 Q1e	2027 Q2e	2027 Q3e	2027 Q4e	2028 Q1e	2028 Q2e	2028 Q3e	2028 Q4e
65	78	76	68	84	85	79	78	91	104	93	102	104	129	119	129	150	172	154	163	180	204	171	163	221	243	230	227	242	250	219	243	234	262	210	225	236	249	207	216	231	278	223	227	234	272	231	232	240	274	277	233	266	267	305	240	299	299	214	240	302	338	302	298	291	351	246	271	389	319	286	285	351	334	289	278	334	375	298	290	315	364	288	304	356	369	315	307	346	389	351	347	356	394	362	360	373	420	379	394
–	20.00	-2.56	-10.53	23.53	1.19	-7.06	-1.27	16.67	14.29	-10.58	9.68	1.96	24.04	-7.75	8.40	16.28	14.67	-10.47	5.84	10.43	13.33	-16.18	-4.68	35.58	9.95	-5.35	-1.30	6.61	3.31	-12.40	10.96	-3.70	11.97	-19.85	7.14	4.89	5.51	-16.87	4.35	6.94	20.35	-19.78	1.79	3.08	16.24	-15.07	0.43	3.45	14.17	1.09	-15.88	14.16	0.38	14.23	-21.31	24.58	–	-28.43	12.15	25.83	11.92	-10.65	-1.32	-2.35	20.62	-29.91	10.16	43.54	-17.99	-10.34	-0.35	23.16	-4.84	-13.47	-3.81	20.14	12.28	-20.53	-2.68	8.62	15.56	-20.88	5.56	17.11	3.65	-14.63	-2.54	12.70	12.43	-9.77	-1.14	2.59	10.67	-8.12	-0.55	3.61	12.60	-9.76	3.96
67.69	67.95	68.42	67.65	67.86	71.76	82.28	80.77	74.73	84.62	79.57	81.37	81.73	83.72	84.03	88.37	88.00	90.12	89.61	89.57	102.22	84.31	88.30	89.57	83.71	87.65	82.61	88.55	88.02	88.40	87.21	89.71	91.03	91.22	90.00	88.00	89.41	90.76	87.92	89.35	90.48	93.88	91.48	94.27	91.45	90.44	89.18	89.22	87.92	91.24	91.34	86.70	88.72	89.89	89.51	87.92	89.63	89.63	84.11	87.08	87.09	89.05	86.75	84.56	87.29	89.74	88.21	84.13	91.00	89.97	89.16	89.12	90.60	89.22	87.54	86.69	89.82	89.07	85.91	87.93	89.84	89.29	87.85	88.82	88.76	90.24	86.03	86.97	87.57	77.89	86.32	87.32	85.11	76.90	83.70	84.17	81.23	72.14	79.95	76.90
44	53	52	46	57	61	65	63	68	88	74	83	85	108	100	114	132	155	138	146	184	172	151	146	185	213	190	201	213	221	191	218	213	239	189	198	211	226	182	193	209	261	204	214	214	246	206	207	211	250	253	202	236	240	273	211	268	268	180	209	263	301	262	252	254	315	217	228	354	287	255	254	318	298	253	241	300	334	256	255	283	325	253	270	316	333	271	267	303	303	303	303	303	303	303	303	303	303	303	303
12	12	12	3	10	10	14	16	17	28	19	25	29	39	29	44	47	56	46	48	78	69	51	44	69	85	63	65	86	82	61	79	73	88	51	51	51	61	30	45	44	75	39	45	41	58	35	46	30	67	63	23	53	50	76	26	-53	65	3	26	98	73	39	43	48	88	67	26	135	76	54	44	80	36	39	27	79	95	16	9	66	97	38	58	67	91	46	49	53	128	96	93	91	137	103	101	103	147	111	119
–	–	–	-75.00	233.33	–	40.00	14.29	6.25	64.71	-32.14	31.58	16.00	34.48	-25.64	51.72	6.82	19.15	-17.86	4.35	62.50	-11.54	-26.09	-13.73	56.82	23.19	-25.88	3.17	32.31	-4.65	-25.61	29.51	-7.59	20.55	-42.05	–	–	19.61	-50.82	50.00	-2.22	70.45	-48.00	15.38	-8.89	41.46	-39.66	31.43	-34.78	123.33	-5.97	-63.49	130.43	-5.66	52.00	-65.79	-303.85	-222.64	-95.38	766.67	276.92	-25.51	-46.58	10.26	11.63	83.33	-23.86	-61.19	419.23	-43.70	-28.95	-18.52	81.82	-55.00	8.33	-30.77	192.59	20.25	-83.16	-43.75	633.33	46.97	-60.82	52.63	15.52	35.82	-49.45	6.52	8.16	141.51	-25.00	-3.13	-2.15	50.55	-24.82	-1.94	1.98	42.72	-24.49	7.21
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.10	0.10	0.10	0.10	0.12	0.12	0.12	0.12	0.14	0.14	0.14	0.14	0.16	0.16	0.16	0.16	0.19	0.19	0.19	0.19	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.25	0.25	0.25	0.25	0.27	0.27	0.27	0.27	0.30	0.30	0.30	0.30	0.33	0.33	0.33	0.33	0.36	0.36	-	-	-	-	-	-	-	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	20.00	–	–	–	16.67	–	–	–	14.29	–	–	–	18.75	–	–	–	15.79	–	–	–	–	–	–	–	13.64	–	–	–	8.00	–	–	–	11.11	–	–	–	10.00	–	–	–	9.09	–	–	–	–	–	–	–	–	–	–	–
90.5	91	95.3	96.8	97.8	105.5	104.2	110.5	110.2	111.4	112	112.2	112.8	113.4	113.7	114.1	114.7	114.7	114.9	115	114.9	115.1	115.5	115.8	116.1	116	115.3	114.3	113.7	113.3	112.3	110.7	109.4	109.2	107.2	104.7	103.5	102.7	103	102.2	103.2	103.9	103.9	103.7	104.3	103.9	104.1	103.1	101.9	101.6	102.7	103.8	103.9	103.9	104.2	102	102.6	107	107	107.1	106.1	104.6	103.7	103.2	103.1	102.8	102.1	103	103.9	104.6	104.6	104.7	103.8	102.7	101.5	99	97	97.3	97.5	98.2	97.44	96.86	96.96	97.06	97.15	97.47	96.9	97.31	96.52	96.52	96.52	96.52	96.52	96.52	96.52	96.52	96.52	96.52	96.52	96.52

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

API Docs Get API Key

Dolby Laboratories stock margins

The Dolby Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Dolby Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Dolby Laboratories.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

Dolby Laboratories Stock Sales Revenue, EBIT, Earnings per Share

The Dolby Laboratories earnings per share therefore indicates how much revenue Dolby Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

Dolby Laboratories business model

Dolby Laboratories Inc. is a leading provider of audio and video technologies. The company was founded in 1965 by Ray Dolby and is headquartered in San Francisco, California. The company's history begins with the invention of noise reduction technology by Ray Dolby. This technology became a worldwide standard for reducing background noise in audio recordings and paved the way for the development of other audio and video technologies. The company's business model is based on licensing its technologies to other manufacturers. Dolby continually develops and enhances its technologies to ensure they keep up with the latest trends and developments in the market. Dolby offers a wide range of audio and video technologies used in various applications, including cinema, home theater, mobile devices, televisions, PCs, and gaming consoles. Some of the company's core products include Dolby Atmos, an advanced audio technology that provides a truly immersive sound experience, Dolby Digital, a standard audio format widely used in cinema and home theater systems, and Dolby Vision, a high dynamic range (HDR) technology that enables more vibrant and realistic color representation. The company operates in various sectors, including broadcast, consumer, content creation, professional, and automotive. In the broadcast sector, the company provides solutions to television and radio broadcasters to ensure better audio and video quality. In the consumer sector, the company offers technologies that can be used in home theater systems, soundbars, mobile devices, and other audio and video applications. In the content creation sector, the company works with film studios, TV broadcasters, music producers, and other content creators to ensure their content is compatible with the latest technologies. In the professional sector, the company provides solutions for audio and video editing and production, including the Dolby Cinema cinema system. Finally, the company is also active in the automotive sector and collaborates with automotive manufacturers to offer better audio and video features. Dolby has established itself as an innovator in the audio and video technology industry over the years. The company holds numerous patents in its name and continuously strives to keep its technologies up to date with the latest trends and developments in the market. With a strong focus on research and development and a commitment to providing the best technologies in the market, Dolby is a brand that many people worldwide trust.

API Docs Get API Key

Dolby Laboratories SWOT Analysis

Strengths

Dolby Laboratories Inc has several strengths that contribute to its success and market leadership. The company holds a strong brand reputation globally, which enhances customer trust and loyalty. Dolby's technology and innovation in audio and video solutions are considered state-of-the-art. The company's extensive patent portfolio ensures its competitive advantage by protecting its intellectual property. Additionally, Dolby has built strategic partnerships with major industry players, facilitating market penetration and product integration.

Weaknesses

Dolby Laboratories Inc also faces certain weaknesses that could impact its performance. The company heavily relies on licensing revenue, which exposes it to potential fluctuations in licensing agreements and royalties. Moreover, Dolby's technology and products are often premium-priced, limiting their accessibility to price-sensitive markets. Dolby's dependence on the entertainment industry for its revenue stream can also pose risks during periods of industry volatility.

Opportunities

Dolby Laboratories Inc has several opportunities to expand its market presence and drive growth. The increasing demand for high-quality audio and video experiences in various sectors, including entertainment, automotive, gaming, and virtual reality, presents new avenues for product development and revenue generation. The rapid growth of streaming platforms and online content delivery provides opportunities for Dolby to enhance its technology integration and licensing partnerships. Furthermore, emerging markets offer untapped potential for Dolby's solutions, particularly in regions with evolving entertainment industries.

Threats

Dolby Laboratories Inc faces certain threats that may impact its operations and market position. Intense competition from both established companies and emerging players in the audio and video technology space poses a challenge to Dolby's market share. Piracy and unauthorized use of Dolby's intellectual property remain persistent threats, requiring ongoing legal efforts to combat infringement. Additionally, economic downturns and fluctuations in consumer spending patterns can affect the demand for premium products, including Dolby's offerings.

API Docs Get API Key

Dolby Laboratories Segments

Dolby Laboratories Revenue by Segment (1/3)

Licensing

Products and services

Details

Dolby Laboratories Revenue by Segment (2/3)

Broadcast

Mobile

Other

Details

Dolby Laboratories Revenue by Segment (3/3)

Reportable Segment

Details

Dolby Laboratories Revenue by Region

3 Years
5 Years
10 Years
Max

International

United States

U.S.

Details

API Docs Get API Key

Dolby Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

Dolby Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Dolby Laboratories's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Dolby Laboratories's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Dolby Laboratories's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Dolby Laboratories grows earnings faster than its peers.

API Docs Get API Key

Dolby Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

Dolby Laboratories shares outstanding

The number of shares was Dolby Laboratories in 2025 — This indicates how many shares 97.479 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

Dolby Laboratories Dividend History

14 years of dividend payments · 11 consecutive increases

YearAnnual DividendYoY ChangePayments

20260.36USDYTD—1×

Feb 10, 20260.36USD 0.0%1/1

20251.35USD↑ 9.8%4×

Feb 11, 20250.33USD 0.0%1/4

May 13, 20250.33USD 0.0%2/4

Aug 12, 20250.33USD 0.0%3/4

Dec 2, 20250.36USD↑ 9.1%4/4

20241.23USD↑ 10.8%4×

20231.11USD↑ 8.8%4×

20221.02USD↑ 12.1%4×

20210.91USD↑ 3.4%4×

20200.88USD↑ 11.4%4×

20190.79USD↑ 17.9%4×

20180.67USD↑ 15.5%4×

20170.58USD↑ 16.0%4×

API Docs Get API Key

Dolby Laboratories dividend history and estimates

In 2025, Dolby Laboratories paid a dividend amounting to 1.35 USD. Dividend means that Dolby Laboratories distributes a portion of its profits to its owners.

Dividend

Dividend (Estimate)

Special dividend

Details

API Docs Get API Key

Dolby Laboratories dividend payout ratio

In 2025, Dolby Laboratories had a payout ratio of 47.13%. The payout ratio indicates the percentage of the company's profits that Dolby Laboratories distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Current Dolby Laboratories forecasts and price targets in March 2026

Δ MOM Price Target	5.56 %
Buy	72.73 % (8)
Hold	27.27 % (3)
Sell	null % (0)
12M Price Target	86.70
Last Price	63.85
Currency	USD
12M Return Potential	35.79 %
LTM Return	0 %

API Docs Get API Key

Dolby Laboratories Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
1/29/2026	0.89USD	335.39 MUSD	2026 Q1
11/18/2025	0.71USD	307.74 MUSD	2025 Q4
11/19/2024	0.7USD	311.02 MUSD	2024 Q4
11/14/2024	0.7USD	311.02 MUSD	2024 Q4
5/2/2024	1.19USD	367.06 MUSD	2024 Q2
1/31/2024	0.86USD	314.2 MUSD	2024 Q1
11/15/2023	0.81USD	321.57 MUSD	2023 Q4
8/7/2023	0.71USD	314.28 MUSD	2023 Q3
5/3/2023	0.97USD	355.06 MUSD	2023 Q2
2/1/2023	1.11USD	369.54 MUSD	2023 Q1
11/17/2022	0.71USD	309.8 MUSD	2022 Q4
8/9/2022	0.59USD	298.45 MUSD	2022 Q3
5/5/2022	0.82USD	337.5 MUSD	2022 Q2
2/3/2022	1.07USD	367.66 MUSD	2022 Q1
11/16/2021	0.57USD	304.45 MUSD	2021 Q4
7/29/2021	0.48USD	282.97 MUSD	2021 Q3
5/4/2021	0.67USD	298.7 MUSD	2021 Q2
1/28/2021	1.05USD	350.51 MUSD	2021 Q1
11/12/2020	0.34USD	248.1 MUSD	2020 Q4
8/3/2020	0.27USD	236.1 MUSD	2020 Q3
5/4/2020	1.1USD	366.77 MUSD	2020 Q2
1/29/2020	0.5USD	290.1 MUSD	2020 Q1
11/14/2019	0.49USD	302.01 MUSD	2019 Q4
8/1/2019	0.49USD	309.87 MUSD	2019 Q3
5/1/2019	0.52USD	342.51 MUSD	2019 Q2
1/30/2019	0.57USD	299.47 MUSD	2019 Q1
10/24/2018	0.3USD	275.74 MUSD	2018 Q4
7/25/2018	0.69USD	322.42 MUSD	2018 Q3
4/24/2018	0.65USD	304.88 MUSD	2018 Q2
1/24/2018	0.44USD	269.74 MUSD	2018 Q1
10/25/2017	0.27USD	248.47 MUSD	2017 Q4
7/25/2017	0.65USD	301.34 MUSD	2017 Q3
4/26/2017	0.47USD	277.94 MUSD	2017 Q2
1/25/2017	0.4USD	258.95 MUSD	2017 Q1
10/26/2016	0.2USD	229.84 MUSD	2016 Q4
7/27/2016	0.51USD	272.06 MUSD	2016 Q3
4/27/2016	0.47USD	267.92 MUSD	2016 Q2
1/27/2016	0.29USD	242.73 MUSD	2016 Q1
10/21/2015	0.32USD	239.3 MUSD	2015 Q4
7/22/2015	0.3USD	238.82 MUSD	2015 Q3
4/21/2015	0.49USD	269.44 MUSD	2015 Q2
1/21/2015	0.38USD	243.06 MUSD	2015 Q1
10/23/2014	0.32USD	219.95 MUSD	2014 Q4
7/24/2014	0.26USD	211.71 MUSD	2014 Q3
4/29/2014	0.5USD	248.44 MUSD	2014 Q2
1/23/2014	0.34USD	215.26 MUSD	2014 Q1
10/29/2013	0.34USD	213.27 MUSD	2013 Q4
7/25/2013	0.3USD	211.73 MUSD	2013 Q3
4/25/2013	0.56USD	249.34 MUSD	2013 Q2
1/29/2013	0.46USD	224.3 MUSD	2013 Q1
11/8/2012	0.45USD	212.81 MUSD	2012 Q4
8/2/2012	0.52USD	221.07 MUSD	2012 Q3
5/3/2012	0.75USD	257.34 MUSD	2012 Q2
1/31/2012	0.63USD	238.18 MUSD	2012 Q1
11/17/2011	0.61USD	233.8 MUSD	2011 Q4
8/4/2011	0.55USD	219.3 MUSD	2011 Q3
5/5/2011	0.72USD	256.17 MUSD	2011 Q2
2/3/2011	0.63USD	238.35 MUSD	2011 Q1
11/4/2010	0.49USD	213.71 MUSD	2010 Q4
7/29/2010	0.51USD	212.1 MUSD	2010 Q3
4/29/2010	0.62USD	221.55 MUSD	2010 Q2
2/3/2010	0.49USD	183.79 MUSD	2010 Q1
11/3/2009	0.33USD	158.98 MUSD	2009 Q4
7/30/2009	0.32USD	149.17 MUSD	2009 Q3
4/30/2009	0.47USD	183.9 MUSD	2009 Q2
2/4/2009	0.43USD	168.07 MUSD	2009 Q1
11/6/2008	0.34USD	148.92 MUSD	2008 Q4
7/31/2008	0.31USD	142.76 MUSD	2008 Q3
5/1/2008	0.42USD	161.51 MUSD	2008 Q2
1/31/2008	0.32USD	136.37 MUSD	2008 Q1
11/8/2007	0.25USD	122.38 MUSD	2007 Q4
8/1/2007	0.2USD	107.71 MUSD	2007 Q3
5/2/2007	0.27USD	117.9 MUSD	2007 Q2
2/1/2007	0.21USD	105.48 MUSD	2007 Q1
11/9/2006	0.12USD	85.07 MUSD	2006 Q4
8/2/2006	0.13USD	85.09 MUSD	2006 Q3
4/27/2006	0.14USD	89.17 MUSD	2006 Q2
1/26/2006	0.09USD	85.68 MUSD	2006 Q1
11/17/2005	0.08USD	71.18 MUSD	2005 Q4
7/28/2005	0.15USD	88.95 MUSD	2005 Q3
5/5/2005	0.18USD	90.14 MUSD	2005 Q2

...

EESG©

Eulerpool ESG Scorecard© for the Dolby Laboratories stock

83/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions975

Scope 2 - Indirect emissions from purchased energy4,592

Scope 3 - Indirect emissions within the value chain83,005

Total CO₂ emissions5,567

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees30.1

Percentage of women in management—

Percentage of Asian employees32

Share of Asian management21.9

Percentage of Hispanic/Latino employees8.2

Hispano/Latino Management share4.7

Percentage of Black employees3.1

Black Management Share2.3

Percentage of white employees53

White Management Share69.5

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

Dolby Laboratories shareholders

%	Name	Stocks	Change	Date
7.88946%	The Vanguard Group, Inc.	7,537,590	+16,424	6/30/2025
6.57820%	Atlanta Capital Management Company, L.L.C.	6,284,815	-35,239	6/30/2025
5.62844%	BlackRock Institutional Trust Company, N.A.	5,377,415	-24,373	6/30/2025
2.51206%	Mellon Investments Corporation	2,400,021	+79,524	6/30/2025
2.36661%	State Street Investment Management (US)	2,261,059	+180,072	6/30/2025
2.15960%	Newton Investment Management North America, LLC	2,063,286	-141,230	6/30/2025
1.81731%	AQR Capital Management, LLC	1,736,260	+592,282	6/30/2025
1.62923%	Geode Capital Management, L.L.C.	1,556,571	+30,057	6/30/2025
1.61066%	Disciplined Growth Investors, Inc.	1,538,824	-8,137	6/30/2025
1.29544%	Frontier Capital Management Company, LLC	1,237,667	+28,243	6/30/2025
1.29521%	First Trust Advisors L.P.	1,237,443	+322,063	6/30/2025
1.21633%	Mackenzie Investments	1,162,079	+14,279	6/30/2025
1.21484%	Acadian Asset Management LLC	1,160,661	+19,840	6/30/2025
1.13898%	Boston Trust Walden Company	1,088,185	-10,033	9/30/2025
1.11234%	Dimensional Fund Advisors, L.P.	1,062,725	+52,482	6/30/2025
1.07821%	Snyder Capital Management, L.P.	1,030,121	+574,554	6/30/2025
0.80181%	Schroder Investment Management North America Inc.	766,047	-232,781	6/30/2025
0.78924%	Charles Schwab Investment Management, Inc.	754,037	-3,957	6/30/2025
0.77563%	Norges Bank Investment Management (NBIM)	741,041	+32,251	6/30/2025
0.73302%	BNY Wealth	700,328	-47,260	6/30/2025
0.69891%	Grantham Mayo Van Otterloo & Co LLC	667,738	+179,026	6/30/2025
0.65268%	Parametric Portfolio Associates LLC	623,568	+39,464	6/30/2025
0.64134%	Fiera Capital Inc.	612,736	-9,438	6/30/2025
0.53283%	UBS Financial Services, Inc.	509,067	+154,772	6/30/2025
0.47064%	Qube Research & Technologies Ltd	449,653	+21,622	6/30/2025
0.46462%	Pacer Advisors, Inc.	443,897	+219,901	9/30/2025
0.45301%	Managed Account Advisors LLC	432,808	+3,747	6/30/2025
0.44124%	Northern Trust Investments, Inc.	421,557	-74,894	6/30/2025
0.42991%	Ninety One UK Limited	410,738	-11,467	9/30/2025
0.39407%	Squarepoint Capital LLP	376,499	+112,541	6/30/2025
0.33016%	Wellington Management Company, LLP	315,436		8/31/2025
0.31735%	Lazard Asset Management, L.L.C.	303,199	-35,910	6/30/2025
0.28944%	Rhumbline Advisers Ltd. Partnership	276,534	+867	6/30/2025
0.28208%	Lord, Abbett & Co. LLC	269,495	-10,628	6/30/2025
0.27639%	Clifford Capital Partners, LLC	264,059	+7,871	6/30/2025
0.27626%	Alps Advisors, Inc.	263,940	-1,794	6/30/2025
0.26502%	Aristotle Capital Management, LLC	253,197	+3,741	6/30/2025
0.25660%	BNY Mellon Asset Management	245,155	-19,921	6/30/2025
0.25519%	Goldman Sachs Asset Management, L.P.	243,807	+136,212	6/30/2025
0.25455%	Martingale Asset Management, L.P.	243,198	+51,867	6/30/2025
0.24672%	California Public Employees' Retirement System	235,719	-41,040	6/30/2025
0.20814%	New York State Common Retirement Fund	198,856	-416	6/30/2025
0.19937%	Trexquant Investment LP	190,482	+16,233	6/30/2025
0.18205%	Mercer Global Investments Management Ltd	173,926	-500	8/31/2025
0.17705%	Yeaman (Kevin J)	169,153	+38,419	12/16/2024
0.17359%	Newton Investment Management Ltd.	165,850	+15,014	1/31/2025
0.17331%	Robeco Institutional Asset Management B.V.	165,577	-17,302	9/30/2025
0.17285%	BlackRock Financial Management, Inc.	165,137	+18,874	6/30/2025
0.16682%	RBC Brewin Dolphin	159,376		7/31/2025
0.15770%	Kayne Anderson Rudnick Investment Management, LLC	150,663	-3,336	6/30/2025
0.15725%	Aperio Group, LLC	150,234	-27,944	6/30/2025
0.15046%	Envestnet Asset Management, Inc.	143,745	-9,594	6/30/2025
0.15003%	BlackRock Investment Management, LLC	143,343	+52,386	6/30/2025
0.14572%	Principal Global Investors (Equity)	139,225	-1,581	6/30/2025
0.13904%	Legal & General Investment Management Ltd.	132,842	+168	6/30/2025
0.13892%	UBS Asset Management (Switzerland)	132,723	+62,546	6/30/2025
0.13195%	Nuveen LLC	126,066	-62,154	6/30/2025
0.13087%	Summit Creek Advisors LLC	125,034	+24,905	9/30/2025
0.13084%	Carnegie Fonder AB	125,000		9/30/2025
0.12246%	Schweizerische Nationalbank	117,000		6/30/2025
0.12199%	Northern Trust Global Investments	116,554	+10,704	6/30/2025
0.11971%	Dimensional Fund Advisors, Ltd.	114,367		9/30/2025
0.11860%	JP Morgan Asset Management	113,314	-5,333	6/30/2025
0.11781%	Cambiar Investors LLC	112,555	+2,606	6/30/2025
0.11171%	JPMorgan Asset Management U.K. Limited	106,724	+50,052	9/30/2025
0.10833%	Ray Dolby Legacy Fund	103,500		1/30/2025
0.10532%	Dagmar Dolby Fund	100,625		1/30/2025
0.10372%	The Treasurer of the State of North Carolina	99,094	+46,664	6/30/2025
0.10173%	Teacher Retirement System of Texas	97,193	+2,646	9/30/2025
0.09772%	Couling (John D)	93,358	-675	5/5/2025
0.09722%	Victory Capital Management Inc.	92,887	+71,346	6/30/2025
0.09486%	Caisse de Depot et Placement du Quebec	90,631	+43,029	12/31/2024
0.09394%	2Xideas AG	89,750	+4,065	6/30/2025
0.09296%	Dolby (David E)	88,810	+3,140	2/4/2025
0.09248%	SEI Investments Management Corporation	88,352	+922	6/30/2025
0.09129%	State Street Investment Management Ireland	87,214	+2,722	9/30/2025
0.09038%	BlackRock Asset Management Ireland Limited	86,346	-25,780	6/30/2025
0.09032%	Goldman Sachs & Company, Inc.	86,296	-55,683	6/30/2025
0.08930%	Comerica, Inc.	85,314	-20,256	6/30/2025
0.08851%	T. Rowe Price Investment Management, Inc.	84,566	-5,736	9/30/2025
0.08167%	Wells Fargo Advisors	78,032	-4,026	6/30/2025
0.08154%	AllianceBernstein L.P.	77,904	-37,197	6/30/2025
0.08114%	ProShare Advisors LLC	77,519	-8,391	6/30/2025
0.08045%	Gotham Asset Management, LLC	76,865	+61,100	6/30/2025
0.07945%	Florida State Board of Administration	75,904	+350	6/30/2025
0.07743%	The Retirement Systems of Alabama	73,975	-1,076	9/30/2025
0.07600%	UBS Fund Management (Switzerland) AG	72,608	-8,425	6/30/2025
0.07491%	Balyasny Asset Management LP	71,567	-140,756	6/30/2025
0.07431%	M. Elsasser Vermögensverwaltung Wealth Management GmbH	71,000		12/31/2024
0.07431%	DZ Bank AG Deutsche Zentral-Genossenschaftsbank	71,000		6/30/2025
0.07390%	Renaissance Technologies LLC	70,600	+66,600	6/30/2025
0.07117%	Thrivent Asset Management, LLC	67,992	+679	6/30/2025
0.07089%	Morgan Stanley Smith Barney LLC	67,729	-9,142	6/30/2025
0.07075%	Corebridge Financial Inc.	67,598	+81	3/31/2025
0.06728%	Invesco Capital Management LLC	64,281	-5,863	6/30/2025
0.06683%	BofA Global Research (US)	63,846	+4,855	6/30/2025
0.06642%	Citadel Advisors LLC	63,460	-55,547	6/30/2025
0.06640%	Invesco Advisers, Inc.	63,435	+1,543	6/30/2025
0.06603%	PIMCO (US)	63,087	-42,949	6/30/2025
0.06576%	IEQ Capital LLC	62,830	+34,466	6/30/2025

...

API Docs Get API Key

Dolby Laboratories Executives and Management Board

Mr. Kevin Yeaman

(58)

President, Chief Executive Officer, Director · since 2005

Compensation9.68 MUSD

Compensation9.68 M USD

Mr. John Couling

(49)

Senior Vice President - Entertainment

3.85 MUSD

Compensation3.85 M USD

Mr. Mark Sherman

(57)

Executive Vice President, General Counsel, Corporate Secretary

3.76 MUSD

Compensation3.76 M USD

Dr. Shriram Revankar

(62)

Senior Vice President, Advanced Technology Group

3.63 MUSD

Compensation3.63 M USD

Mr. Robert Park

(54)

Chief Financial Officer, Senior Vice President

3.35 MUSD

Compensation3.35 M USD

API Docs Get API Key

Dolby Laboratories Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite

30 companies

#	Name	1M	3M	6M	1Y	2Y
1	Walt Disney Supplier	0,37	-0,15	0,61	0,83	0,91
2	Sonos Supplier	0,23	-0,57	0,31	0,75	0,87
3	Lenovo Group Supplier	-0,05	-0,13	0,55	0,23	0,77
4	Logitech International Supplier	0,29	-0,56	0,64	0,80	0,77
5	Mercedes-Benz Group Supplier	0,48	0,24	0,55	0,48	0,74

#	Name	1M	3M	6M	1Y	2Y
1	Videlio	-0,22	0,15	-0,40	-0,73	—
2	Vimeo Supplier	0,34	-0,56	0,64	0,81	—
3	Anghami Supplier	0,37	-0,23	—	—	—
4	VIZIO Holding A Supplier	0,14	-0,37	0,80	0,87	—
5	Lucid Group Supplier	0,14	-0,72	0,75	0,13	—

API Docs Get API Key

Dolby Laboratories Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for Dolby Laboratories and thousands of other companies.

Most common questions regarding Dolby Laboratories

Dolby Laboratories Inc, a renowned company in the entertainment industry, operates through a licensing business model. By designing and developing audio and imaging technologies, Dolby licenses its innovative solutions to manufacturers across various industries. These technologies enhance the audio and visual experiences of movies, music, games, and broadcasts, ensuring superior quality and immersive content delivery. Dolby's business model centers around collaborations with partners who integrate Dolby technologies into their products, amplifying the overall consumer experience. Continuously pushing the boundaries of innovation, Dolby Laboratories Inc remains dedicated to providing cutting-edge audio and visual technologies to create captivating and exceptional entertainment experiences.

Dolby Laboratories Inc. is a leading company in the development and provision of innovative audio technologies for cinema, home theater, mobile devices, and other applications. They have received over 700 patents worldwide for their technologies and work with leading manufacturers. Dolby's business model includes several divisions, including technology licensing for audio and video products, the development of audio tools for professional applications, and the provision of software and services for mobile devices. Dolby's core competence lies in the development and enhancement of audio technologies. They have developed a range of advanced technologies that enable their customers to create better and higher-quality audio experiences. Their portfolio includes technologies such as Dolby Digital Plus, Dolby Surround 7.1, Dolby TrueHD, Dolby Atmos, Dolby Voice, and Dolby Vision. Dolby licensing involves granting licenses for third parties to use their technologies. Manufacturers of audio and video products can integrate Dolby technologies into their devices to offer better audio and video quality that meets industry standards. Dolby has partnerships with leading audio device manufacturers like Samsung, LG Electronics, Sony, and many others. Dolby also offers a comprehensive range of audio tools for professional audio post-production. These tools allow professional sound engineers to create and mix sound for films, TV shows, music, and video games. Dolby tools such as Dolby Atmos Mastering Suite and Dolby Vision enable users to create an immersive and impressive audio and video experience for their clients. Another important division of Dolby is the provision of software and services for mobile devices. They work with leading manufacturers and operating system providers like Apple, Samsung, Microsoft, and Google to integrate Dolby technologies into their mobile devices. Dolby Atmos for Headphones and Dolby Digital Plus for Mobile are some of the products that Dolby has developed for the mobile market. In summary, Dolby Laboratories Inc. is a company that has developed innovative technologies for the audio and video industry. With a wide range of products and services, they have established themselves as a leading company in audio technology. Dolby works closely with leading manufacturers and partners to provide their customers with excellent audio and video quality.

API Docs Get API Key

Fair ValuePRO

58.58 USD

Over-/UndervaluationPRO

11.0% undervalued

Expected Return

12.99 %

Sector

Information technology

Industry

Electronic Components

Number of shares

95,540,000

Employees

2,193

Revenue per Employee

615,198.36 USD

Revenue growth Ø5 years

1.04 %

EBIT growth Ø5 years

-3.86 %

Net Income growth Ø5 years

-3.84 %

Website dolby.com

Country

United States 🇺🇸

Currency

USD

Initial public offering

Feb 17, 2005

ISIN

US25659T1079

Cusip

25659T107

Sedol

B04NJM9

Market capitalization

6.31 B USDMid Cap

52-Week Range

63.78–69.2USD

Dolby Laboratories Directors Dealings

Quality Investing

Details

5 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

4.61

P/E ratio

24.34

P/Ee 2026

14.78

P/Ee 2027

13.88

P/Ee 2028

12.66

P/S

4.6

P/Se

4.33

EV/EBIT

20.02

P/B Ratio

2.41

ROE (Return on Equity)

9.72 %

ROA (Return on Assets)

7.9 %

ROCE (Return on Capital Employed)

10.68 %

ROIC (Return on Invested Capital)

13.28 %

Gross Margin

88.13 %

EBIT Margin

20.75 %

Net Margin

18.9 %

EPS (Earnings Per Share)

2.62 USD

Net Debt / EBIT

-2.51

Debt/Equity

Dividend

1.35 USD

Dividend yield

2.12 %

Est. Dividend Yield

0.57 %

Payout Ratio

47.13 %

Dividend growth Ø5Y

8.21 %

Dividend payments per year

Dividend paid since

11 years+

Dividend not reduced since

10 years+

Dividend increased since

10 years+

Dividend withholding tax

30 %

Last updated Mar 12, 2026, 2:02 AM

Dolby Laboratories Peer Group

Oracle Corp

Palo Alto Networks Inc

Vishay Intertechnology Inc

II-VI Inc

Rogers Corp

CrowdStrike Holdings Inc

Dolby Laboratories Ticker

DÜSSELDORF · FUO.DUFRANKFURT · FUO.FMUNICH · FUO.MUNEW YORK · DLBSIX · FUO.SWXETRA · FUO.DE

Dolby Laboratories FIGI

FUO:GR · BBG000CBY5M8FUO:GF · BBG000CBY5R3FUO:GD · BBG000CBY6B8FUO:GS · BBG000CBY726FUO:GM · BBG000CBY7W3FUO:GB · BBG000CBZ9P6DLB:US · BBG000DGLTG5DLB:UA · BBG000DGLTX6DLB:UC · BBG000DGLVG0DLB:UN · BBG000DGLWP8DLB:UP · BBG000DGLX12DLB:UB · BBG000DGLXC0DLB:UT · BBG000DGLY83DLB:UM · BBG000DGLYS1DLB:UX · BBG000DGLZL5DLB:UD · BBG000DGM2X4DLB:UF · BBG000DGM4F0DLB:VY · BBG000DGM4P9DLB:VJ · BBG000DGM5B1DLB:VK · BBG000DGM5T2DLB:VF · BBG00DJFJVF2FUO:TH · BBG00DWWPYD9DLB2EUR:EO · BBG00DX3DL43DLB2EUR:XH · BBG00DX3DL70DLB2EUR:XF · BBG00DX3DL98DLB2EUR:XE · BBG00DX3DLC4DLB2EUR:XJ · BBG00DX3DLD3DLB2EUR:XL · BBG00DX3DLF1DLB2EUR:XG · BBG00DX3DLG0DLB2EUR:XO · BBG00DX3DLH9DLB2EUR:XS · BBG00DX3DLM3DLB2EUR:XA · BBG00DX3DLN2DLB2EUR:E1 · BBG00DX3DLP0DLB2EUR:XT · BBG00DX3DLQ9DLB2EUR:XW · BBG00DX3DLR8DLB2EUR:XU · BBG00DX3DLS7DLB2EUR:XV · BBG00DX3DLT6DLB2EUR:EU · BBG00DX3DLW2FUO:QT · BBG00DYNJ1G3FUO:GZ · BBG00FZMHJ72DLB2EUR:XX · BBG00JN8K0J2DLB2USD:X2 · BBG00JRYQX67DLB2USD:XB · BBG00JRYQX76DLB2USD:XH · BBG00JRYQXB1DLB2USD:XF · BBG00JRYQXF7DLB2USD:XE · BBG00JRYQXH5DLB2USD:XJ · BBG00JRYQXK1DLB2USD:XL · BBG00JRYQXL0DLB2USD:XG · BBG00JRYQXM9DLB2USD:XO · BBG00JRYQXP6DLB2USD:XS · BBG00JRYQXV9DLB2USD:XA · BBG00JRYQXW8DLB2USD:E1 · BBG00JRYQXY6DLB2USD:XT · BBG00JRYQXZ5DLB2USD:XW · BBG00JRYQY01DLB2USD:XU · BBG00JRYQY29DLB2USD:XV · BBG00JRYQY38DLB2USD:XM · BBG00JRYQY47DLB2USD:XQ · BBG00JRYQY74DLB2USD:XX · BBG00JRYQY83DLB2USD:XZ · BBG00JRYQYB9DLB2USD:EU · BBG00JRYQYK9DLB2GBP:XS · BBG00L4V30C3DLB2GBP:XH · BBG00L4V30G9DLB2GBP:XF · BBG00L4V30J6DLB2GBP:XE · BBG00L4V30L3DLB2GBP:XJ · BBG00L4V30M2DLB2GBP:XL · BBG00L4V30N1DLB2GBP:XG · BBG00L4V30P9DLB2GBP:XO · BBG00L4V30Q8DLB2GBP:XA · BBG00L4V30V2DLB2GBP:E1 · BBG00L4V30W1DLB2GBP:XT · BBG00L4V30X0DLB2GBP:XW · BBG00L4V30Y9DLB2GBP:XU · BBG00L4V30Z8DLB2GBP:XV · BBG00L4V3104DLB2GBP:XM · BBG00L4V3113DLB2GBP:XQ · BBG00L4V3122DLB2GBP:XX · BBG00L4V3131DLB2GBP:XZ · BBG00L4V3140DLB2GBP:EU · BBG00L4V3168FUO:SW · BBG00LVD7Q14FUO:BW · BBG00LVD7Q78DLB:VG · BBG00X1MVN57DLB:VP · BBG00X1R95N0FUO:LA · BBG018H7VMD0FUO:LU · BBG018J1HQ02

All fundamentals about Dolby Laboratories

Our stock analysis for Dolby Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dolby Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Dolby Laboratories Revenue→

Dolby Laboratories Net Income→

Dolby Laboratories P/E→

Dolby Laboratories P/S→

Dolby Laboratories EBIT→

Dolby Laboratories Dividend→

Dolby Laboratories Directors Dealings→

Dolby Laboratories Stocks→

Dolby Laboratories Market capitalization→

Dolby Laboratories Debt→

Dolby Laboratories Liabilities→

Dolby Laboratories Equity→

Dolby Laboratories AAQS→

Dolby Laboratories Employees→

Dolby Laboratories ROE→

Dolby Laboratories ROA→

Dolby Laboratories ROCE→